4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-005752
President sold 30,000 shares at an average $65.52 ($1,965,509)
- President acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-01-25 | Option exercise | +15,000 | $6.32 | $94,800 | 15,000 | D |
| RUBINSTEIN JULIE President | 2021-01-25 | Sale | −3,871 | $65.09 | $251,963 | 11,129 | D |
| RUBINSTEIN JULIE President | 2021-01-25 | Sale | −1,813 | $65.89 | $119,459 | 9,316 | D |
| RUBINSTEIN JULIE President | 2021-01-25 | Sale | −8,816 | $67.05 | $591,113 | 500 | D |
| RUBINSTEIN JULIE President | 2021-01-25 | Sale | −500 | $67.79 | $33,895 | 0 | D |
| RUBINSTEIN JULIE President | 2021-01-26 | Option exercise | +15,000 | $6.32 | $94,800 | 15,000 | D |
| RUBINSTEIN JULIE President | 2021-01-26 | Sale | −10,930 | $64.32 | $703,018 | 4,070 | D |
| RUBINSTEIN JULIE President | 2021-01-26 | Sale | −3,470 | $65.28 | $226,522 | 600 | D |
| RUBINSTEIN JULIE President | 2021-01-26 | Sale | −600 | $65.90 | $39,540 | 0 | D |
| Derivatives | |||||||
| RUBINSTEIN JULIE President | 2021-01-25 | Option exercise · Stock Option (Right to Buy) | −15,000 | 155,000 | D | ||
| RUBINSTEIN JULIE President | 2021-01-26 | Option exercise · Stock Option (Right to Buy) | −15,000 | 140,000 | D | ||
| Open-market sales · 30,000 sh · avg $65.52 · $1,965,509 | |||||||
Loading xslF345X03/doc4.xml…